Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02659423 · ClinicalTrials.gov registry record
Multi-College Bystander Efficacy Evaluation
A clinical trial, sponsored by Ann Coker.
- Completed
- Registry status
- 24
- Enrollment target
NCT02659423: Completed study, sponsored by Ann Coker.
NCT02659423 is a clinical trial that has completed, run by Ann Coker. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02659423 has completed, sponsored by Ann Coker.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
Bystander interventions, recognized as promising violence prevention strategies, are unique in their engagement of all community members to 1) recognize situations that may become violent and 2) learn to safely and effectively intervene to reduce violence risk. Based on their promise, the Campus Sexual Violence Elimination Act (SaVE) now requires all publicly-funded colleges to provide bystander intervention. With SaVE's policy intervention requiring bystander interventions, a "natural experiment" has arisen to determine the relative efficacy of students' bystander training across multiple colleges. Investigators propose a quasi-experimental design (using fractional factorials) to evaluate the relative efficacy of three bystander interventions to reduce violence in college communities. Green Dot will be one of three bystander interventions evaluated. A recent rigorous evaluation has found that Green Dot is associated with a 20-40% reduction in VAW in college and high school settings. In aim 1, investigators will compare the relative efficacy of bystander interventions to a) increase bystander efficacy and behaviors, b) reduce violence acceptance, c) reduce interpersonal violence victimization and perpetration, and d) increase program cost effectiveness. The three main bystander groups compared will be: exclusively online training, Green Dot (speeches and intensive bystander training), and other skills-based bystander training. Program efficacy data will be obtained from student surveys, campus crime statistics, and surveys with college staff and administrators responsible for selecting and implementing bystander interventions. In aim 2, investigators seek to grow communities of VAW prevention researchers. Researcher communities will form through researchers' engagement with college recruitment, survey design, data collection and analyses. Specifically investigators will determine the efficacy of this program to increase VAW prevention research productivity defined
Primary Outcome
Interpersonal Violence defined as sexual violence, partner violence, stalking and sexual harassment
Interventions
- BEHAVIORAL BIC 1
- BEHAVIORAL BIC 2
- BEHAVIORAL BIC 3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2016-01 |
| Est. Completion | 2020-12 |
What the finished NCT02659423 record still lists
NCT02659423 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which BIC 1 is the first listed.
NCT02659423 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02659423 about?
NCT02659423 is a clinical study titled "Multi-College Bystander Efficacy Evaluation". Bystander interventions, recognized as promising violence prevention strategies, are unique in their engagement of all community members to 1) recognize situations that may become violent and 2) learn to safely and effectively intervene to reduce violence risk. Based on their promise, the Campus Sex...
What is the current status of trial NCT02659423?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2016-01. Estimated completion is 2020-12.
What interventions are being tested in trial NCT02659423?
The interventions under investigation include: BIC 1 (BEHAVIORAL), BIC 2 (BEHAVIORAL), BIC 3 (BEHAVIORAL).
Who is sponsoring clinical trial NCT02659423?
This trial is sponsored by Ann Coker, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia